← back to picks

HQ Seoul · South Korea Listing KOSPI:271560 Reporting KRW Structure operating company Damodaran FCFF · 1000-iter MC Corrections KRW rf + governance-in-flows FCFF · Dark v3

A pro-minority EM compounder behind a chaebol cascade · +24% after two methodology fixes

BUY — survives the rf correction, helped by the governance re-spec

Orion is a globally-diversified confectionery compounder (Choco Pie #1 across China, Vietnam and Russia), net-cash and debt-free, behind a Korean chaebol cascade. This revision applies two methodology fixes: the KRW risk-free is corrected up to the blended 3.66% (it was the lowest in the book), and governance is re-specified from a flat 0.18 to an in-flows treatment with a 0.15 residual — because Orion passes both viability conditions (rising dividend + a 3.97% treasury-share cancellation, and a Value-Up plan with teeth). Net, fair value is ₩170,235 vs a ₩129,600 price (+24% margin of safety, +31% to price) — down from +35%, still a BUY: the Monte-Carlo 5th percentile (₩156,075) clears the price by ~20%, and not one of 1,000 draws lands below it.

StructureOperating company (not the holdco 001800)Balance sheetNet-cash · debt-free · ~₩1.4T cashCash returnDiv +40% (2025) · 3.97% treasury cancel 2026β / WACC0.935 hardened · WACC 9.11%GovernanceIn-flows + 15% residual (was flat 18%)VerdictBUY · +24% MoS (both corrections applied)

Intrinsic / share

₩170,235

post 15% gov · pre ₩200,277

Market / share

₩129,600

late-May 2026 · KOSPI:271560 · rf + governance corrected

Margin of safety

+31.4%

vs intrinsic

Enterprise value

₩6.63T

58.5% terminal

Cost of equity / debt

9.15% / 3.17%

β 0.94 · CRP 1.64%

Terminal ROIC / g

11.00% / 2.00%

spread ~189bp (ROIC 11.00% vs WACC 9.11%)

What it sells, where it sells

Operating segments

Chinalargest profit pool42%

South Koreamature cash cow29%

Vietnamfastest-quality growth16%

Russiafastest grower (ruble/sanction tail)10%

Indiasecond-decade option3%

A single consolidated operating company, but the value is geographic: Korea (~29%) is a flat, royalty-rich cash cow, while China / Vietnam / Russia / India (~71%) are the compounding engine. The Choco Pie cross-EM brand moat (the #1 line in China, Vietnam and Russia) holds the consolidated operating margin ~6pts above the Food Processing median. Russia (~9.5%) carries the ruble/sanctions tail.

Country mix (revenue-weighted CRP input)

🇨🇳China42%

🇰🇷South Korea29%

🇻🇳Vietnam16%

🇷🇺Russia10%

🇮🇳India3%

Revenue-geography weights drive the country-risk premium (weighted CRP ≈ 1.64%). Russia's ~2.56% CRP (≈6× Korea's) does most of the lifting despite a ~9.5% weight; China is a parallel geopolitical dependency (the 2017 THAAD boycott is the precedent). This is the geopolitical tail the discount rate prices.

Background — five things to know before the case

Context the share price doesn't carry on its face. Skim this once and the bull / bear bullets below stop reading as inside baseball.

This is the operating company, not the holdco. Orion Corp (271560) makes and sells the snacks; the family controls via Orion Holdings (001800, ~63.9% family → 37.4% of the opco). Minorities sit two layers below the controlling family — the cascade is the governance issue, priced as a residual, not in the operating flows.
A genuine net-cash EM compounder. ~₩1.4T cash, debt-free, self-funding an ₩830B 2025–27 capacity build. FY21–25 revenue compounded ~9%; ~71% of sales are overseas (China, Vietnam, Russia, India), behind the Choco Pie moat that holds the margin ~6pts above the Food Processing median.
It is unusually pro-minority for a chaebol name. Four straight years of dividend hikes (payout 18.8%→36%, 2025 DPS +40%), a board-approved Korea Value-Up plan (payout ≥20% rising), AND a planned cancellation of 3.97% of shares in 2026 — buyback-and-cancel, the strongest cash-return signal. It passes both viability conditions cleanly.
The bear case is the cascade, not the business. A ₩550B non-core LigaChem biotech bet (the market punished it −20%; the associate is lossmaking), Holdings-level cash extraction (Holdings has paid dividends > net income to build a succession war-chest), and a Stellaway tunnelling precedent. These feed the 0.15 residual.
Two methodology corrections in this revision. The KRW risk-free was the lowest in the book (2.5%, off a stale 2.9% 10Y) → blended up to 3.66%; and the flat 0.18 governance discount → an in-flows treatment with a 0.15 residual. The first cuts the MoS, the second adds back; net +24%.

Where we diverge from the sector

Each row asks: if we'd used the sector median for this one assumption instead of our override, how much would the share price change? Negative = our override is more conservative (worth less); positive = more aggressive (worth more). Skim down the rightmost column to see which bets are doing the work.

Assumption

Our input

Prior / sector

Effect

01KRW risk-freeCorrection 1 — low-yield-currency blend

3.66%65/35 blend of bond−spread (3.48%) and inflation-parity (3.99%); the prior 2.9% 10Y was a stale input

2.50% (prior)Built off a too-low 2.9% 10Y bond

−value

02Governance discountCorrection 2 — modelled in-flows, residual trimmed

0.15Residual only (Holdings extraction + tunnelling + non-core M&A), net of value-up + treasury cancellation

0.18 (flat, prior)Flat end-discount, not in-flows

+value

03Operating margin (Y10)Moat premium over the Food Processing median

16.5%Inside the 15.8–17.5% historical band; Choco Pie cross-EM moat

10.6%Food Processing US median

+value

04Terminal ROCFaded from the ~24% the inputs imply (carries the capital-misallocation drag)

11.0%A real but bounded moat excess over the ~9.1% WACC (~190bp); the LigaChem-style misallocation drag lives here

~24% (unfaded)Indefensible held-forever

conservative

05Beta / WACCHardened for EM/geopolitical concentration

0.935WACC 9.11% — an EM premium on top of the triangulated β_u 0.56; overlaps the higher rf

0.56 (triangulated)Food Processing β_u, CoE ~5.8%

conservative

Net effect of the two corrections

Two methodology fixes, opposite signs. (1) The KRW risk-free was the lowest in the Korean book (2.5%, off a stale 2.9% 10Y); corrected to the blended 3.66% with terminal g un-pinned to 2.0% inflation, it lifts WACC 7.95%→9.11% and cuts value. (2) Governance was a flat 0.18 end-discount — the anti-pattern; run through the controlled-company discipline (Orion passes BOTH viability conditions — rising dividend + treasury cancellation, and a Value-Up plan with teeth), with the capital-misallocation drag already in the flows (ROC fade; LigaChem carried at zero), the residual trims to 0.15 and adds value. Net: ₩199,915 → ₩170,235, MoS +35% → +24%. Still a BUY at the base blend and the high bookend alike.

₩170.2k

Our input Prior / sector Adds value Subtracts value

The story & the five claims

The 10-year story this DCF is built on, plus the five anchor claims that translate the story into engine inputs.

The 10-year story

Orion is the rare Korean controlled name where the operating business is unambiguously good and the argument is entirely about governance and the discount rate. The business is a four-engine overseas confectionery franchise — a flat, cash-rich Korea anchor plus China, Vietnam, Russia and India compounding behind the Choco Pie brand — net-cash, debt-free, self-funding its own capacity build, with an operating margin that has held 15.8–17.5% for five straight years, six points above the sector. And it is unusually pro-minority for a chaebol: four straight years of dividend increases, a Korea Value-Up plan with real numbers, and a planned cancellation of nearly 4% of its shares in 2026 — the cash-return signals the controlled-company methodology prizes most. So it passes both viability tests, cleanly. Two corrections land in this revision. First, the risk-free: Orion had been discounted at 2.5% — the lowest rate in the entire Korean book, off a stale 2.9% ten-year yield — so we blend it up to 3.66% per the low-yield-currency methodology and un-pin terminal growth to 2.0% inflation, which lifts WACC to 9.1% and cuts fair value. Second, governance: the old model bolted a flat 18% discount on the end, the exact anti-pattern the controlled-company discipline forbids. The real governance drag — the LigaChem capital destruction — is already in the flows (the ₩550B is carried at zero and the faded terminal ROC absorbs the misallocation), so the residual, for ongoing Holdings extraction and tunnelling risk net of the strong value-up, trims to 0.15. The first correction takes value down, the second adds some back: net, fair value moves from ₩199,915 to ₩170,235, a +24% margin of safety. Cheap at the base blend and the high bookend alike, with a third of the market cap in cash — still a BUY, just a more honestly-specified one.

Two debates worth pressure-testing

Isn't cutting governance 0.18→0.15 just making it cheaper?

Our view: No — it's correctness. A flat 0.18 end-discount is the anti-pattern; the controlled-company methodology says model governance in the flows and reserve a small residual. Orion's capital-misallocation drag is already in the flows (LigaChem carried at zero; ROC faded), and it passes both viability conditions (rising dividend + 3.97% treasury cancellation; Value-Up with teeth), so the residual belongs at the ≤0.15 ceiling. And the rf correction (cutting value) more than offsets it — net MoS fell +35%→+24%.

Does the cascade justify a residual above navien's 0.15?

Our view: No. Navien's controller-as-supplier is confirmed, quantified tunnelling (a KFTC fine); Orion's cascade is a structural risk with strong pro-minority offsets (value-up, cancellation). So Orion sits at — not above — the 0.15 residual ceiling, same as navien. The LigaChem destruction is the bigger flag, and that's already in the flows, not the residual.

CLAIM 01Passes both viability conditions — a strong anomaly.rising div + 3.97% treasury cancel · Value-Up plan4 straight years of dividend hikes (payout 18.8%→36%) AND a 2026 buyback-and-cancellation, plus a dated Value-Up plan. Controls its own cash — not a trap.

CLAIM 0216.5% operating margin — a real moat premium.Y10 op margin 16.5%Inside the 15.8–17.5% five-year band, ~6pts above the Food Processing median. Choco Pie cross-EM brand + in-country manufacturing.

CLAIM 03Governance modelled in the flows, not bolted on.LigaChem ₩550B at cross_holdings: 0 · ROC faded 24%→11%The capital destruction is priced by omission in the flows; the faded ROC carries the misallocation drag. The 0.15 residual is only the leakage the flows can't catch.

CLAIM 04KRW risk-free corrected to the methodology blend.rf 2.5% → 3.66% · terminal g → 2.0%Was the lowest rf in the book, off a stale 2.9% 10Y. Blended 65/35; terminal g un-pinned to inflation. Lifts WACC to 9.1%.

CLAIM 05Residual governance discount trimmed to the ceiling.governance_discount: 0.18 → 0.15Holdings extraction + Stellaway tunnelling + non-core-M&A risk, net of the strong value-up. At the methodology ≤0.15 residual ceiling; same as navien.

Where we diverge from sell-side

We set the risk-free to the currency, not the stale bond. 2.5% was the lowest in the Korean book; we blend to 3.66% per the low-yield-currency methodology.
We model governance in the flows, not as a flat end-discount. The LigaChem destruction is carried at zero and the ROC fade absorbs the misallocation; only a 0.15 residual remains.
We credit the value-up + cancellation. Buyback-and-cancel and a dated Value-Up plan are real pro-minority cash return — the reason the residual sits at 0.15, not 0.18.
We harden β to 0.935 for EM/geopolitical concentration. A conscious premium over the triangulated β_u 0.56; it overlaps the higher rf, so +24% is conservative.
We fade terminal ROC to 11%. Rather than compound the ~24% the inputs imply — a bounded ~190bp moat excess over WACC.

Two-sided case — bear anchors

Holdings-level cash extraction deepens. Holdings has paid dividends above net income to fund succession; a worse extraction or another LigaChem-style bet would justify a residual above 0.15. The central bear case.
Russia / China geopolitical tail. A ruble devaluation, sanctions tightening, or a THAAD-style China boycott hits ~50%+ of profit. Priced via the CRP and the MC tail.
The risk-free climbs further. At the 3.99% high bookend, fair value compresses; a sustained KRW rate regime above that would keep pressuring a terminal-heavy value.
The value-up reverses. If the dividend hikes stall or the treasury cancellation is cancelled, the 0.15 residual is too generous and should widen back toward 0.18+.
Capacity build under-converts. The ₩830B build assumes the new lines fill; a slower ramp keeps reinvestment efficiency below 2.0 and depresses ROIC longer.

Risks to thesis (tail, not bear case)

Holdings extraction / cascadeHigh

The central bear case. Holdings-level dividend extraction, the ₩550B LigaChem non-core bet, the Stellaway precedent. Priced as the 0.15 residual; a worse outcome justifies more.

Russia / China geopolitical tailHigh

~50%+ of profit sits in China + Russia. Ruble devaluation, sanctions, or a THAAD-style boycott. Priced via the CRP (~1.64%) and the Monte-Carlo tail.

KRW risk-free regimeMed

Now corrected to the blended 3.66% (was 2.5%). A terminal-heavy value stays rate-sensitive even after the fix; the 3.99% high bookend compresses it further.

Value-up reversalMed

The 0.15 residual credits the dividend hikes + 2026 treasury cancellation. If those stall, the residual should widen back toward 0.18+ and the MoS shrinks.

Capacity-build conversionLow

₩830B 2025–27 build must fill to lift sales-to-capital toward 2.0. A slow ramp keeps ROIC depressed and softens the back half.

10-year forecast

Revenue compounds ₩3.67T → ₩5.61T over 10y (~6% fading to 2.0% terminal); operating margin holds ~16.5%, ~6pts above the Food Processing median on the Choco Pie moat. FCFF is strongly positive throughout (net-cash compounder) — the value is real operating cash. The LigaChem ₩550B stake is carried at zero, so its capital destruction is in the flows by omission, not the tail discount.

Monte Carlo distribution

Across 1,000 correlated draws — growth, margin, terminal growth, β/WACC and the residual governance discount stressed jointly — the p5 outcome is ₩156.1k/share, still ~20% above the ₩129,600 price, and not one draw lands below the market (P(intrinsic < market) = 0.0%). The distribution is tighter than before (σ ₩8,414) because the corrected, higher risk-free and the lower terminal growth remove the low-rate tail that previously inflated the upside. The residual the MC can't sample is the discrete governance/geopolitical event.

Mean ₩169,457 ± ₩8,414/sh, 1000 iterations (0 failed). P(intrinsic < market ₩129,600) = 0.0%.

Cost of capital build

Risk-free rate	3.66%
Mature-market ERP	4.23%
Levered β	0.94
Weighted CRP	1.64%
Cost of equity	9.15%
Pre-tax cost of debt (synth Aaa/AAA)	4.06%
D / V	~1%
WACC	9.11%

Full year-by-year DCF

Year	Revenue	Op mgn	EBIT	EBIT(1−t)	Reinvest	FCFF	PV
1	₩3.67T	16.98%	₩622.94B	₩442.91B	₩122.15B	₩320.76B	₩293.97B
2	₩3.89T	16.86%	₩655.65B	₩466.17B	₩129.48B	₩336.69B	₩282.80B
3	₩4.12T	16.74%	₩690.05B	₩490.62B	₩137.25B	₩353.37B	₩272.02B
4	₩4.37T	16.62%	₩726.20B	₩516.33B	₩145.49B	₩370.84B	₩261.63B
5	₩4.63T	16.50%	₩764.22B	₩543.36B	₩154.22B	₩389.14B	₩251.61B
6	₩4.88T	16.50%	₩804.72B	₩583.26B	₩122.74B	₩460.52B	₩273.16B
7	₩5.10T	16.50%	₩841.74B	₩621.71B	₩112.17B	₩509.54B	₩277.54B
8	₩5.30T	16.50%	₩874.57B	₩658.03B	₩99.48B	₩558.55B	₩279.64B
9	₩5.47T	16.50%	₩902.55B	₩691.54B	₩84.81B	₩606.73B	₩279.49B
10	₩5.61T	16.50%	₩925.12B	₩721.59B	₩68.38B	₩653.22B	₩277.13B

Methodology & flags

Damodaran FCFF DCF, 10y explicit + perpetuity, in KRW. Risk-free 3.66% (local-currency government bond). Synthetic credit Aaa/AAA. CRP 1.64% from revenue-weighted country mix × Damodaran 2026 CRPs. Terminal ROIC faded to 11.00%; 15% governance haircut applied post-DCF. Monte Carlo: 1000 iterations. Engine v1.0.0 · result: /Users/valentin/Documents/notes_jiliac_labs/Finance/Damodaran/valuations/orion/output/2026-06-01-result.json

R&D cap: OFF · Lease cap: OFF · Failure: OFF · ESO: OFF
Governance haircut: 15% applied post-DCF (₩200,277 > ₩170,235)
Sensitivity tornado: not run

FCFF DCF · dark theme v3. Generated 2026-06-01T10:49:25 from /Users/valentin/Documents/notes_jiliac_labs/Finance/Damodaran/valuations/orion/output/2026-06-01-result.json.